Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J3OZ
|
|||
| Former ID |
DNC006245
|
|||
| Drug Name |
2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile
|
|||
| Synonyms |
CHEMBL202748; 2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile; SCHEMBL5889065
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H5N5S
|
|||
| Canonical SMILES |
C1=CN=CN=C1NC2=NC=C(S2)C#N
|
|||
| InChI |
1S/C8H5N5S/c9-3-6-4-11-8(14-6)13-7-1-2-10-5-12-7/h1-2,4-5H,(H,10,11,12,13)
|
|||
| InChIKey |
SMNGUXOKYVUIRA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 436852-19-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1146-50. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.